“SLC39A1 contributes to gemcitabine resistance of pancreatic ductal adenocarcinoma by activating AMPK signaling”, Bangladesh J Pharmacol, vol. 19, no. 2, pp. 52–58, Jun. 2024, doi: 10.3329/bjp.v19i2.72787.